Article Details
Retrieved on: 2022-12-06 18:16:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
This program will expand Pfizer's innovative anti-infective pipeline and, if successful, will complement Pfizer's existing portfolio of COVID-19 ...
Article found on: www.pfizer.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here